欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	DE/H/3066/001
药品名称	Cranoc 20mg Hartkapseln
活性成分	fluvastatin sodium salt 21.06 mg
剂型	Capsule, hard
上市许可持有人	Novartis Pharma GmbH Roonstr. 25 90429 Nürnberg Germany
参考成员国 - 产品名称	Germany (DE) Cranoc 20mg Hartkapseln
互认成员国 - 产品名称	Italy (IT)
许可日期	2011/01/05
最近更新日期	2021/11/10
药物ATC编码	C10AA04 fluvastatin
申请类型	TypeLevel1：[not specified] TypeLevel2：[not specified] TypeLevel3：[not specified] TypeLevel4：[not specified] TypeLevel5：[not specified]
附件文件下载	Final Product Information \| Cranoc - common-combined-20mgDate of last change:2018/12/18 Final Product Information \| Lescol - common-combined-20mgDate of last change:2018/12/18 Final Product Information \| Lescol - common-combined-40mgDate of last change:2018/12/18 Final Product Information \| Cranoc - common-combined-40mgDate of last change:2018/12/18 Final Product Information \| Cranoc - common-combined-80mgDate of last change:2018/12/18 Final Product Information \| Lescol - common-combined-80mgDate of last change:2018/12/18 Final SPC \| m 1.3.1_Lescol 20 mg Capsules_Track_April 2017Date of last change:2017/09/07 Final SPC \| m 1.3.1_Lescol 40 mg Capsules_Clean_April 2017Date of last change:2017/09/07 Final SPC \| m 1.3.1_Lescol 20 mg Capsules_Clean_April 2017Date of last change:2017/09/07 Final SPC \| m 1.3.1_Lescol XL 80 mg Prolonged-release tablets_Clean_April 2017Date of last change:2017/09/07 Final SPC \| m 1.3.1_Lescol 40 mg Capsules_Track_April 2017Date of last change:2017/09/07 Final SPC \| m 1.3.1_Lescol XL 80 mg Prolonged-release tablets_Track_April 2017Date of last change:2017/09/07
市场状态	Positive